Earl P. Steinberg, M.D., M.P.P. (Vice Chair), is senior vice president for Integrated Health Strategy and Evaluation at WellPoint, Inc., and president and chief executive officer CEO of Resolution Health, Inc., a wholly owned subsidiary of WellPoint Inc. He is a nationally recognized expert in evaluation and improvement of the quality and efficiency of health care. He has had considerable experience in development of evidence-based clinical practice guidelines and of performance measures based on them, as well as with interventions to increase compliance with them. At the IOM, Dr. Steinberg served on the Committee on Medicare Payment Methodology for Clinical Laboratory Services and the Evaluation Panel of the Council on Health Care Technology. Prior to joining Resolution Health, Dr. Steinberg was vice president of Covance Health Economics and Outcomes Services, Inc., where he was also codirector of the Outcomes Studies Group and director of the Quality Assessment and Improvement Systems Division. Dr. Steinberg spent 12 years as a full-time faculty member at Johns Hopkins University, where he was a professor of medicine, a professor of health policy and management, and the founder and director of the Johns Hopkins Program for Medical Technology and Practice Assessment. Dr. Steinberg has spent many years on the Blue Cross Blue Shield Association’s National Medical Advisory Panel. Dr. Steinberg received his A.B. from Harvard College, his M.D. from Harvard Medical School, and his M.P.P. from the Kennedy School of Government at Harvard. He performed his residency training in internal medicine at the Massachusetts General Hospital.

Andrew Auerbach, M.D., M.P.H., is associate professor of medicine in residence at the University of California–San Francisco (UCSF) and a clinician–researcher in the Division of Hospital Medicine. He joined the faculty at UCSF as the nation’s first hospitalist clinician–researcher in 1998. Dr. Auerbach retains an active clinical practice as a hospitalist—both as a ward attending and as an attending on the medical consultation service. In addition to leading clinical practice standardization and order-entry projects at UCSF, his research there has focused primarily on assessments of patient outcomes in different systems of care, with a special interest in the hospitalist model. Additionally he has concentrated on novel approaches to clinical practice translation through enhanced performance measurement. He did his medical residency training at Yale-New Haven Hospital, and a Fellowship in General Internal Medicine at Harvard and Beth Israel Deaconess Medical Center.

Jerome Avorn, M.D., is a professor of medicine at Harvard Medical School and chief of the Division of Pharmacoepidemiology and

The National Academies of Sciences, Engineering, and Medicine
500 Fifth St. N.W. | Washington, D.C. 20001

Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement